Related references
Note: Only part of the references are listed.EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Annick Desjardins et al.
CLINICAL CANCER RESEARCH (2008)
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens
Stephanie E. Combs et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan
Sith Sathornsumetee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Clinical evaluation and follow-up outcome of diffusion tensor IMAGING-BASED functional neuronavigation: A prospective, controlled study in patients with gliomas involving pyramidal tracts
Jin-Song Wu et al.
NEUROSURGERY (2007)
Diagnosis and treatment of high-grade astrocytoma
Sith Sathornsumetee et al.
NEUROLOGIC CLINICS (2007)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Long-term survival with glioblastoma multiforme
Dietmar Krex et al.
BRAIN (2007)
Long-term use of cellular phones and brain tumours:: increased risk associated with use for ≥10 years
Lennart Hardell et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2007)
Molecularly targeted therapy for malignant glioma
Sith Sathornsumetee et al.
CANCER (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors
Damien Faury et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
Inhibiting kinases in malignant gliomas
Andrew S. Chi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials
Jan C. Buckner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation
Victor A. Levin et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
High-grade astrocytoma treated concomitantly with estramustine and radiotherapy
R Henriksson et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Different angiogenic phenotypes in primary and secondary glioblastomas
S Karcher et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Recent advances in the treatment of malignant astrocytoma
DA Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adding chloroquine to conventional treatment for glioblastoma multiforme -: A randomized, double-blind, placebo-controlled trial
J Sotelo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial
PWA Willems et al.
JOURNAL OF NEUROSURGERY (2006)
Gliadel® wafer in initial surgery for malignant glioma:: long-term follow-up of a multicenter controlled trial
M Westphal et al.
ACTA NEUROCHIRURGICA (2006)
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
D Xie et al.
BRITISH JOURNAL OF CANCER (2006)
Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors
Zbigniew Wygoda et al.
HYBRIDOMA (2006)
Malignant glioma: Neuropathology and Neurobiology
Matthias Preusser et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Adult glioma incidence trends in the United States, 1977-2000
KR Hess et al.
CANCER (2004)
Brain tumours: Classification and genes
VP Collins
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
R. Capocaccia et al.
ANNALS OF ONCOLOGY (2003)
Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma
M Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Incidences of gliomas and meningiomas in Denmark, 1943 to 1997
HC Christensen et al.
NEUROSURGERY (2003)
Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers
DM Long et al.
NEUROSURGERY (2003)
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394
SA Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine
RG Selker et al.
NEUROSURGERY (2002)
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C→A:T mutations of the TP53 tumor suppressor gene
M Nakamura et al.
CARCINOGENESIS (2001)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Genome maintenance mechanisms for preventing cancer
JHJ Hoeijmakers
NATURE (2001)
Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization
ABY Hui et al.
LABORATORY INVESTIGATION (2001)
Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas
M Labuhn et al.
ONCOGENE (2001)
Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial
D Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
G Fulci et al.
ONCOGENE (2000)
Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
A von Deimling et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Share Paper
